{
  "data_version": "seed-0.6 · 2026-08-29",
  "source": "https://finance.foundation",
  "license": "CC BY 4.0",
  "entity": "company",
  "data": {
    "id": "astrazeneca",
    "name": "AstraZeneca",
    "legal_name": "AstraZeneca PLC",
    "ticker": "AZN",
    "exchange": "lse",
    "country": "united-kingdom",
    "sector": "Healthcare",
    "industry": "Pharmaceuticals",
    "market_cap_usd_bn": 230,
    "currency": "GBP",
    "website": "https://www.astrazeneca.com",
    "founded": 1999,
    "description": "Anglo-Swedish pharmaceutical company formed by the 1999 merger of Astra AB and Zeneca Group, with major franchises in oncology, cardiovascular and rare diseases. One of the largest companies on the London Stock Exchange.",
    "identifiers": {
      "lei": "PY6ZZQWO2IZFZC3IOL08",
      "isin": "GB0009895292",
      "figi": "BBG001SCNW31"
    }
  },
  "links": {
    "html": "https://finance.foundation/companies/astrazeneca",
    "graph": "https://finance.foundation/api/v1/graph/companies/astrazeneca"
  }
}